1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Breast Cancer Screening Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Breast Cancer Screening Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Breast Cancer Screening Market Regional Analysis
6.2 Europe Breast Cancer Screening Market Revenue 2017-2027 (US$ Million)
6.3 Europe Breast Cancer Screening Market Forecast Analysis
7. Europe Breast Cancer Screening Market Analysis – by Test Type
7.1 Blood Marker Test
- 7.1.1 Overview
- 7.1.2 Blood Marker Test: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Imaging Test
- 7.2.1 Overview
- 7.2.2 Imaging Test: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Genetic Test
- 7.3.1 Overview
- 7.3.2 Genetic Test: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Immunohistochemistry Test
- 7.4.1 Overview
- 7.4.2 Immunohistochemistry Test: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Breast Cancer Screening Market Analysis – by End User
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Diagnostic Centers
- 8.2.1 Overview
- 8.2.2 Diagnostic Centers: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Cancer Institutes
- 8.3.1 Overview
- 8.3.2 Cancer Institutes: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Research Laboratories
- 8.4.1 Overview
- 8.4.2 Research Laboratories: Europe Breast Cancer Screening Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Breast Cancer Screening Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Breast Cancer Screening Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Europe Breast Cancer Screening Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 UK: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.2.1.1.2 UK: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.2.1.2 Germany:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Germany: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.2.1.2.2 Germany: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.2.1.3 France:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 France: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.2.1.3.2 France: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.2.1.4 Russia:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Russia: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.2.1.4.2 Russia: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.2.1.5 Italy:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Italy: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.2.1.5.2 Italy: Europe Breast Cancer Screening Market Breakdown, by End User
- 9.2.1.6 Rest of Europe:
Europe Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Breast Cancer Screening Market Breakdown, by Test Type
- 9.2.1.6.2 Rest of Europe: Europe Breast Cancer Screening Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Koninklijke Philips N.V.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hologic, Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Becton, Dickinson and Company
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Myriad Genetics, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Siemens Healthcare AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Exact Sciences Corporation
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 OncoCyte Corporation
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 POC Medical Systems
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 DanaherCorporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 General Electric Company
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Breast Cancer Screening Market
